National Vision (EYE) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $17.66, +3.70% vs the prior close of $17.03.
- Volume 1.45M shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
EYE jumps 3.7% to $17.66, a 1-month high. Closed at $17.66, +3.70% vs the prior close of $17.03. Day range $17.25–$18.01, opened at $17.25.
EYE daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — EYE jumps 3.7% to $17.66, a 1-month high
- Closed at $17.66, +3.70% vs the prior close of $17.03. Day range $17.25–$18.01, opened at $17.25.
- Volume was 1.45M shares, 0.7x its 50-day average of 2.22M.
- Price is -0.0% vs its 50-day average ($17.67) and -19.2% vs its 200-day average ($21.86).
- 52-week range $14.75–$30.02; today's close sits at 19% of that range, 41.2% below the 52-week high.
Oct 14, 2026 — EYE ends flat (-0.1%) to $17.03
- Closed at $17.03, -0.06% vs the prior close of $17.04. Day range $16.45–$17.03, opened at $16.83.
- Volume was 1.48M shares, 0.7x its 50-day average of 2.23M.
- Price is -4.2% vs its 50-day average ($17.77) and -22.3% vs its 200-day average ($21.91).
- 52-week range $14.75–$30.02; today's close sits at 15% of that range, 43.3% below the 52-week high.
Oct 13, 2026 — EYE ends flat (-0.2%) to $17.04
- Closed at $17.04, -0.18% vs the prior close of $17.07. Day range $16.85–$17.64, opened at $17.23.
- Volume was 1.24M shares, 0.6x its 50-day average of 2.23M — lighter than usual.
- Price is -4.8% vs its 50-day average ($17.90) and -22.4% vs its 200-day average ($21.96).
- 52-week range $14.75–$30.02; today's close sits at 15% of that range, 43.2% below the 52-week high.
Oct 12, 2026 — EYE rises 2.3% to $17.07
- Closed at $17.07, +2.34% vs the prior close of $16.68. Day range $16.31–$17.12, opened at $16.53.
- Volume was 1.37M shares, 0.6x its 50-day average of 2.24M.
- Price is -5.2% vs its 50-day average ($18.00) and -22.5% vs its 200-day average ($22.02).
- 52-week range $14.75–$30.02; today's close sits at 15% of that range, 43.1% below the 52-week high.
Oct 9, 2026 — EYE dips 0.4% to $16.68
- Closed at $16.68, -0.36% vs the prior close of $16.74. Day range $16.53–$16.82, opened at $16.71.
- Volume was 975.60K shares, 0.4x its 50-day average of 2.24M — lighter than usual.
- Price is -7.9% vs its 50-day average ($18.10) and -24.4% vs its 200-day average ($22.07).
- 52-week range $14.75–$30.02; today's close sits at 13% of that range, 44.4% below the 52-week high.
Oct 8, 2026 — EYE dips 0.5% to $16.74
- Closed at $16.74, -0.48% vs the prior close of $16.82. Day range $16.50–$17.00, opened at $16.70.
- Volume was 2.13M shares, 1.0x its 50-day average of 2.23M.
- Price is -8.1% vs its 50-day average ($18.22) and -24.4% vs its 200-day average ($22.13).
- 52-week range $14.75–$30.02; today's close sits at 13% of that range, 44.2% below the 52-week high.
Oct 7, 2026 — EYE rises 0.5% to $16.82, 3 up days in a row
- Closed at $16.82, +0.48% vs the prior close of $16.74. Day range $16.48–$17.20, opened at $16.59.
- Volume was 2.51M shares, 1.1x its 50-day average of 2.22M.
- Price is -8.2% vs its 50-day average ($18.32) and -24.2% vs its 200-day average ($22.19).
- 52-week range $14.75–$30.02; today's close sits at 14% of that range, 44.0% below the 52-week high.
- That makes 3 straight gains.
Oct 6, 2026 — EYE rises 1.3% to $16.74
- Closed at $16.74, +1.33% vs the prior close of $16.52. Day range $16.44–$16.93, opened at $16.64.
- Volume was 1.55M shares, 0.7x its 50-day average of 2.23M.
- Price is -9.1% vs its 50-day average ($18.42) and -24.8% vs its 200-day average ($22.25).
- 52-week range $14.75–$30.02; today's close sits at 13% of that range, 44.2% below the 52-week high.
Oct 5, 2026 — EYE rises 0.7% to $16.52
- Closed at $16.52, +0.73% vs the prior close of $16.40. Day range $16.17–$16.72, opened at $16.47.
- Volume was 1.66M shares, 0.7x its 50-day average of 2.22M.
- Price is -10.7% vs its 50-day average ($18.50) and -25.9% vs its 200-day average ($22.31).
- 52-week range $14.75–$30.02; today's close sits at 12% of that range, 45.0% below the 52-week high.
Oct 2, 2026 — EYE ends flat (+0.0%) to $16.40
- Closed at $16.40, +0.00% vs the prior close of $16.40. Day range $16.27–$16.86, opened at $16.67.
- Volume was 2.11M shares, 1.0x its 50-day average of 2.22M.
- Price is -11.7% vs its 50-day average ($18.57) and -26.7% vs its 200-day average ($22.37).
- 52-week range $14.75–$30.02; today's close sits at 11% of that range, 45.4% below the 52-week high.
EYE latest news & SEC filings
Every SEC filing by or about EYE in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 21, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 4, 2026:
- Revenue: $498.81M (prior year $486.42M) (+2.5% vs Jun 28, 2025)
- Net income: $12.42M (prior year $8.72M) (+42.3% vs Jun 28, 2025)
- Diluted EPS: $0.15 (prior year $0.11) (+36.4% vs Jun 28, 2025)
Aug 12, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 6, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 31, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 9, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade EYE
- Last results release: Aug 12, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 11, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.99% (largest 3.7%). That is a relatively calm stock.
- Liquidity: about 2.06M shares (≈$36.32M) trade per day on average.
- 52-week position: $17.66 vs a range of $14.75–$30.02 (19% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 3 sales; latest: Michael J Nicholson bought 50,000 shares on Jun 5, 2026.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 12, 2026; 8-K Jun 22, 2026.
- Share count: 79.07M shares outstanding (Jul 31, 2026), -0.2% vs a year earlier.
- Listing: Nasdaq · industry: Ophthalmic Goods.
EYE market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 17.25 | 18.01 | 17.25 | 17.66 | 1.45M |
| Oct 14, 2026 | 16.83 | 17.03 | 16.45 | 17.03 | 1.48M |
| Oct 13, 2026 | 17.23 | 17.64 | 16.85 | 17.04 | 1.24M |
| Oct 12, 2026 | 16.53 | 17.12 | 16.31 | 17.07 | 1.37M |
| Oct 9, 2026 | 16.71 | 16.82 | 16.53 | 16.68 | 975.60K |
| Oct 8, 2026 | 16.70 | 17.00 | 16.50 | 16.74 | 2.13M |
| Oct 7, 2026 | 16.59 | 17.20 | 16.48 | 16.82 | 2.51M |
| Oct 6, 2026 | 16.64 | 16.93 | 16.44 | 16.74 | 1.55M |
| Oct 5, 2026 | 16.47 | 16.72 | 16.17 | 16.52 | 1.66M |
| Oct 2, 2026 | 16.67 | 16.86 | 16.27 | 16.40 | 2.11M |
| Oct 1, 2026 | 16.48 | 16.62 | 16.24 | 16.40 | 1.71M |
| Sep 30, 2026 | 16.55 | 16.69 | 16.11 | 16.38 | 1.59M |
| Sep 29, 2026 | 16.20 | 16.58 | 16.12 | 16.38 | 1.67M |
| Sep 28, 2026 | 16.38 | 16.62 | 15.91 | 16.12 | 2.38M |
| Sep 25, 2026 | 16.57 | 16.81 | 16.41 | 16.53 | 1.34M |
| Sep 24, 2026 | 16.52 | 16.71 | 16.14 | 16.41 | 1.72M |
| Sep 23, 2026 | 16.48 | 16.82 | 16.02 | 16.36 | 2.39M |
| Sep 22, 2026 | 16.80 | 17.00 | 15.95 | 16.60 | 5.10M |
| Sep 21, 2026 | 17.05 | 17.12 | 16.43 | 16.45 | 1.65M |
| Sep 18, 2026 | 16.82 | 16.93 | 16.58 | 16.88 | 5.11M |
About National Vision
National Vision (EYE) is listed on the Nasdaq and classified by the SEC under “Ophthalmic Goods”. Its business address is in ALPHARETTA, GA. State of incorporation: DE. Fiscal year ends January 2. SEC CIK 1710155.
EYE board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jose Armario | Director | Jun 22, 2026 |
| L Reade Fahs | Executive Chairman | Mar 9, 2026 |
| Virginia A Hepner | Director | Jun 22, 2026 |
| Susan S Johnson | Director | Jun 22, 2026 |
| Naomi Kelman | Director | Jun 22, 2026 |
| James M. Mcgrann | Director | Jun 22, 2026 |
| Michael J Nicholson | Director | Jun 22, 2026 |
| Susan C Ofarrell | Director | Jun 22, 2026 |
| Alexander Wilkes | Chief Executive Officer | Aug 21, 2026 |
| Caitlin Zulla | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mark Banner | President, America's Best | Jul 9, 2026 |
| Jared Brandman | Chief Legal & Strategy Officer | Apr 30, 2026 |
| Bill Clark | Chief People Officer | Mar 9, 2026 |
| David G Cutler | Chief Technology Officer | Sep 9, 2026 |
| L Reade Fahs | Executive Chairman | Mar 9, 2026 |
| Christopher Laden | Chief Financial Officer | Apr 1, 2026 |
| Ana Moeddel | CHIEF MERCH. & MC OFFICER | Sep 3, 2026 |
| Priti V Patel | Head of Emerging Brands | Mar 9, 2026 |
| Joseph Vandette | Chief Brand & Mktg Officer | Mar 9, 2026 |
| Alexander Wilkes | Chief Executive Officer | Aug 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 5, 2026 | Michael J Nicholson | Buy | 50,000 | $15.52 |
| Mar 11, 2026 | Alexander Wilkes | Sale | 35,000 | $26.54 |
| Mar 6, 2026 | L Reade Fahs | Sale | 7,601 | $29.58 |
| Mar 6, 2026 | L Reade Fahs | Sale | 4,071 | $29.57 |
EYE financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jan 3, 2026 | $1.99B | $29.60M | 0.37 | $146.29M |
| Dec 28, 2024 | $1.82B | $-28.50M | -0.36 | $133.65M |
| Dec 30, 2023 | $1.76B | $-65.90M | -0.84 | $173.03M |
| Dec 31, 2022 | $1.64B | $42.12M | 0.52 | $119.20M |
| Jan 1, 2022 | $2.08B | $128.24M | 1.43 | $258.94M |
Latest balance sheet: total assets $1.98B, total liabilities $—, cash $36.00M (as of Jul 4, 2026).
EYE earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 12, 2026 | 8-K Item 2.02 (results) | $19.51 |
| May 13, 2026 | 8-K Item 2.02 (results) | $16.92 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $29.04 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $24.70 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $23.88 |
| May 7, 2025 | 8-K Item 2.02 (results) | $15.61 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $12.77 |
| Jan 16, 2025 | 8-K Item 2.02 (results) | $10.75 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $11.89 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Feb 27, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Ophthalmic Goods
Cooper Companies (COO)Alcon (ALC)Warby Parker (WRBY)Bausch & Lomb (BLCO)Staar Surgical (STAA)RxSight (RXST)Innovative Eyewear (LUCY)Innovative Eyewear (LUCYW)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on EYE
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.